NWF Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
NWF Advisory Services's BMY Position: Q1 2026 in Review
NWF Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2026, buying an estimated $9.39K and bringing the position to 6,565 shares worth $398K. The position accounts for 0.05% of the portfolio, ranked #241.
NWF Advisory Services first reported a position in BMY in Q1 2023 and has held it in 12 quarters since. The position peaked at $399K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- NWF Advisory Services held 6,565 shares of Bristol-Myers Squibb worth $398K as of Q1 2026.
- NWF Advisory Services bought 161 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.39K.
- Bristol-Myers Squibb made up 0.05% of NWF Advisory Services's portfolio in Q1 2026, its #241 holding.
- NWF Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 12 quarters since.
- NWF Advisory Services's Bristol-Myers Squibb position peaked at $399K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.